目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Mental Health Clinical Trials Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing prevalence of mental health issues across the globe
3.2.1.2. Increasing drug pipeline for mental health conditions
3.2.2. Market restraint analysis
3.2.2.1. Limited awareness in developing economies pertaining to mental health issues
3.3. Dental Regeneration: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Major Deals & Strategic Alliances Analysis
3.3.4. COVID-19 Impact Analysis

Chapter 4. Mental Health Clinical Trials Market: Phase Estimates & Trend Analysis
4.1. Definitions and Scope
4.2. Mental Health Clinical Trials Market Share, 2022 & 2030
4.3. Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following
4.3.1. Phase I
4.3.1.1. Phase I Market 2018 to 2030 (USD Million)
4.3.2. Phase II
4.3.2.1. Phase II Market 2018 to 2030 (USD Million)
4.3.3. Phase III
4.3.3.1. Phase III Market 2018 to 2030 (USD Million)
4.3.4. Phase IV
4.3.4.1. Phase IV Market 2018 to 2030 (USD Million)

Chapter 5. Mental Health Clinical Trials Market: Study Design Estimates & Trend Analysis
5.1. Definitions and Scope
5.2. Mental Health Clinical Trials Market Share, 2022 & 2030
5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.3.1. Interventional
5.3.1.1. Interventional Market 2018 to 2030 (USD Million)
5.3.2. Observational
5.3.2.1. Observational Market 2018 to 2030 (USD Million)
5.3.3. Others
5.3.3.1. Others Market 2018 to 2030 (USD Million)

Chapter 6. Mental Health Clinical Trials Market: Sponsor Estimates & Trend Analysis
6.1. Definitions and Scope
6.2. Mental Health Clinical Trials Market Share, 2022 & 2030
6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.3.1. Interventional Pharmaceutical & Biopharmaceutical Companies
6.3.1.1. Hospitals & Universities Market 2018 to 2030 (USD Million)
6.3.2. Government Agencies
6.3.2.1. Government Agencies Market 2018 to 2030 (USD Million)
6.3.3. Others
6.3.3.1. Others Market 2018 to 2030 (USD Million)

Chapter 7. Mental Health Clinical Trials Market: Disorder Estimates & Trend Analysis
7.1. Definitions and Scope
7.2. Mental Health Clinical Trials Market Share, 2022 & 2030
7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.3.1. Anxiety Disorders
7.3.1.1. Anxiety Disorders Market 2018 to 2030 (USD Million)
7.3.2. Depression
7.3.2.1. Depression Market 2018 to 2030 (USD Million)
7.3.3. Bipolar affective disorder
7.3.3.1. Bipolar affective disorder Market 2018 to 2030 (USD Million)
7.3.4. Dissociation and dissociative disorders
7.3.4.1. Dissociation and dissociative disorders Market 2018 to 2030 (USD Million)
7.3.5. Schizophrenia
7.3.5.1. Schizophrenia Market 2018 to 2030 (USD Million)
7.3.6. Others
7.3.6.1. Others Market 2018 to 2030 (USD Million)

Chapter 8. Mental Health Clinical Trials Market: Regional Estimates & Trend Analysis
8.1. Regional market share analysis, 2022 & 2030
8.2. Market Size, & Forecasts, Revenue and Trend Analysis, 2018 to 2030:
8.3. North America
8.3.1. North America Mental Health Clinical Trials Market, 2018 - 2030 (USD Million)
8.3.2. U.S.
8.3.2.1. U.S. Mental Health Clinical Trials Market, 2018 - 2030 (USD Million)
8.3.3. Canada
8.3.3.1. Canada Mental Health Clinical Trials Market, 2018 - 2030 (USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. UK Mental Health Clinical Trials Market, 2018 - 2030 (USD Million)
8.4.2. Germany
8.4.2.1. Germany Mental Health Clinical Trials Market, 2018 - 2030 (USD Million)
8.4.3. France
8.4.3.1. France Mental Health Clinical Trials Market , 2018 - 2030 (USD Million)
8.4.4. Italy
8.4.4.1. Italy Mental Health Clinical Trials Market , 2018 - 2030 (USD Million)
8.4.5. Spain
8.4.5.1. Spain Mental Health Clinical Trials Market , 2018 - 2030 (USD Million)
8.4.6. Denmark
8.4.6.1. Denmark Mental Health Clinical Trials Market , 2018 - 2030 (USD Million)
8.4.7. Sweden
8.4.7.1. Sweden Mental Health Clinical Trials Market , 2018 - 2030 (USD Million)
8.4.8. Norway
8.4.8.1. Norway Mental Health Clinical Trials Market , 2018 - 2030 (USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Japan Mental Health Clinical Trials Market , 2018 - 2030 (USD Million)
8.5.2. China
8.5.2.1. China Mental Health Clinical Trials Market , 2018 - 2030 (USD Million)
8.5.3. India
8.5.3.1. India Mental Health Clinical Trials Market, 2018 - 2030 (USD Million)
8.5.4. Australia
8.5.4.1. Australia Mental Health Clinical Trials Market, 2018 - 2030 (USD Million)
8.5.5. Thailand
8.5.5.1. Thailand Mental Health Clinical Trials Market, 2018 - 2030 (USD Million)
8.5.6. South Korea
8.5.6.1. South Korea Mental Health Clinical Trials Market, 2018 - 2030 (USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Brazil Mental Health Clinical Trials Market , 2018 - 2030 (USD Million)
8.6.2. Mexico
8.6.2.1. Mexico Mental Health Clinical Trials Market , 2018 - 2030 (USD Million)
8.6.3. Argentina
8.6.3.1. Argentina Mental Health Clinical Trials Market , 2018 - 2030 (USD Million)
8.7. MEA
8.7.1. South Africa
8.7.1.1. South Africa Mental Health Clinical Trials Market , 2018 - 2030 (USD Million)
8.7.2. Saudi Arabia
8.7.2.1. Saudi Arabia Mental Health Clinical Trials Market , 2018 - 2030 (USD Million)
8.7.3. UAE
8.7.3.1. UAE Mental Health Clinical Trials Market , 2018 - 2030 (USD Million)
8.7.4. Kuwait
8.7.4.1. Kuwait Mental Health Clinical Trials Market , 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Company Profiles
9.1.1. ICON Plc.
9.1.1.1. Company overview
9.1.1.2. Financial Performance
9.1.1.3. Service benchmarking
9.1.1.4. Strategic initiatives
9.1.2. Eli Lilly Company
9.1.2.1. Company overview
9.1.2.2. Financial performance
9.1.2.3. Service benchmarking
9.1.2.4. Strategic initiatives
9.1.3. Caidya
9.1.3.1. Company overview
9.1.3.2. Financial performance
9.1.3.3. Service benchmarking
9.1.3.4. Strategic initiatives
9.1.4. Syneous Health
9.1.4.1. Company overview
9.1.4.2. Financial performance
9.1.4.3. Service benchmarking
9.1.4.4. Strategic initiatives
9.1.5. Novo Nordisk
9.1.5.1. Company overview
9.1.5.2. Financial performance
9.1.5.3. Service benchmarking
9.1.5.4. Strategic initiatives
9.1.6. Pharmaceutical Product Development, LLC
9.1.6.1. Company overview
9.1.6.2. Financial performance
9.1.6.3. Service benchmarking
9.1.6.4. Strategic initiatives
9.1.7. Parexel International Corporation
9.1.7.1. Company overview
9.1.7.2. Financial performance
9.1.7.3. Service benchmarking
9.1.7.4. Strategic initiatives
9.1.8. Corcept
9.1.8.1. Company overview
9.1.8.2. Financial performance
9.1.8.3. Service benchmarking
9.1.8.4. Strategic initiatives
9.1.9. Labcorp Drug Development
9.1.9.1. Company overview
9.1.9.2. Financial performance
9.1.9.3. Service benchmarking
9.1.9.4. Strategic initiatives
9.1.10. IQVIA
9.1.10.1. Company overview
9.1.10.2. Financial performance
9.1.10.3. Service benchmarking
9.1.10.4. Strategic initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Market research approaches
Fig. 4 QFD modelling for market share assessment
Fig. 5 Market formulation & validation
Fig. 6 Commodity flow analysis
Fig. 7 Primary research pattern
Fig. 8 Primary interviews in North America
Fig. 9 Primary interviews in Europe
Fig. 10 Primary interviews in Asia Pacific
Fig. 11 Primary interviews in Latin America
Fig. 12 Primary interviews in MEA
Fig. 13 Market Snapshot
Fig. 14 Segment Snapshot
Fig. 15 Segment Snapshot
Fig. 16 Competitive Landscape Snapshot
Fig. 17 Mental Health Clinical Trials Market segmentation
Fig. 18 Parent market outlook (2022)
Fig. 19 Related/ancillary market outlook (2022)
Fig. 20 Market driver relevance analysis (Current & future impact)
Fig. 21 Current shared services and outsourcing usage levels
Fig. 22 Market restraint relevance analysis (Current & future impact)
Fig. 23 Porter’s five forces analysis
Fig. 24 SWOT analysis, by a factor (political & legal, economic and technological)
Fig. 25 Mental Health Clinical Trials Market Phase outlook: Segment dashboard
Fig. 26 Mental Health Clinical Trials: phase movement analysis
Fig. 27 Phase I market, 2018 - 2030 (USD Million)
Fig. 28 Phase II market, 2018 - 2030 (USD Million)
Fig. 29 Phase III market, 2018 - 2030 (USD Million)
Fig. 30 Phase IV market, 2018 - 2030 (USD Million)
Fig. 31 Mental Health Clinical Trials Market study design outlook: Segment dashboard
Fig. 32 Interventional market, 2018 - 2030 (USD Million)
Fig. 33 Observational market, 2018 - 2030 (USD Million)
Fig. 34 Others market, 2018 - 2030 (USD Million)
Fig. 35 Mental Health Clinical Trials Market sponsor outlook: Segment dashboard
Fig. 36 Mental Health Clinical Trials Market: sponsor movement analysis
Fig. 37 Pharmaceutical & Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
Fig. 38 Government Agencies market, 2018 - 2030 (USD Million)
Fig. 39 Others market, 2018 - 2030 (USD Million)
Fig. 40 Mental Health Clinical Trials Market Disorder outlook: Segment dashboard
Fig. 41 Mental Health Clinical Trials Market: Disorder movement analysis
Fig. 42 Anxiety Disorders market, 2018 - 2030 (USD Million)
Fig. 43 Depression market, 2018 - 2030 (USD Million)
Fig. 44 Bipolar affective disorder market, 2018 - 2030 (USD Million)
Fig. 45 Dissociation and dissociative disorders market, 2018 - 2030 (USD Million)
Fig. 46 Schizophrenia market, 2018 - 2030 (USD Million)
Fig. 47 Others disorder market, 2018 - 2030 (USD Million)
Fig. 48 Regional marketplace: Segment dashboard
Fig. 49 Regional outlook, 2022 & 2030
Fig. 50 North America market, 2018 - 2030 (USD Million)
Fig. 51 U.S. market, 2018 - 2030 (USD Million)
Fig. 52 Canada market, 2018 - 2030 (USD Million)
Fig. 53 Europe market, 2018 - 2030 (USD Million)
Fig. 54 Germany market, 2018 - 2030 (USD Million)
Fig. 55 UK market, 2018 - 2030 (USD Million)
Fig. 56 France market, 2018 - 2030 (USD Million)
Fig. 57 Italy market, 2018 - 2030 (USD Million)
Fig. 58 Spain market, 2018 - 2030 (USD Million)
Fig. 59 Denmark market, 2018 - 2030(USD Million)
Fig. 60 Sweden market, 2018 - 2030 (USD Million)
Fig. 61 Norway market, 2018 - 2030 (USD Million)
Fig. 62 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 63 China market, 2018 - 2030 (USD Million)
Fig. 64 Japan market, 2018 - 2030 (USD Million)
Fig. 65 India market, 2018 - 2030 (USD Million)
Fig. 66 Australia market, 2018 - 2030 (USD Million)
Fig. 67 South Korea market, 2018 - 2030 (USD Million)
Fig. 68 Latin America market, 2018 - 2030 (USD Million)
Fig. 69 Brazil market, 2018 - 2030 (USD Million)
Fig. 70 Mexico market, 2018 - 2030 (USD Million)
Fig. 71 Argentina market, 2018 - 2030 (USD Million)
Fig. 72 MEA market, 2018 - 2030 (USD Million)
Fig. 73 South Africa market, 2018 - 2030 (USD Million)
Fig. 74 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 75 UAE market, 2018 - 2030 (USD Million)
Fig. 76 Kuwait market, 2018 - 2030 (USD Million)